BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26344808)

  • 1. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach.
    Hemming K; Taljaard M
    J Clin Epidemiol; 2016 Jan; 69():137-46. PubMed ID: 26344808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs.
    Hemming K; Lilford R; Girling AJ
    Stat Med; 2015 Jan; 34(2):181-96. PubMed ID: 25346484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. swdpwr: A SAS macro and an R package for power calculations in stepped wedge cluster randomized trials.
    Chen J; Zhou X; Li F; Spiegelman D
    Comput Methods Programs Biomed; 2022 Jan; 213():106522. PubMed ID: 34818620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation.
    Sarkodie SK; Wason JM; Grayling MJ
    Clin Trials; 2023 Feb; 20(1):59-70. PubMed ID: 36086822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering.
    Teerenstra S; Taljaard M; Haenen A; Huis A; Atsma F; Rodwell L; Hulscher M
    Clin Trials; 2019 Jun; 16(3):225-236. PubMed ID: 31018678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power calculation for cross-sectional stepped wedge cluster randomized trials with variable cluster sizes.
    Harrison LJ; Chen T; Wang R
    Biometrics; 2020 Sep; 76(3):951-962. PubMed ID: 31625596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepped wedge designs could reduce the required sample size in cluster randomized trials.
    Woertman W; de Hoop E; Moerbeek M; Zuidema SU; Gerritsen DL; Teerenstra S
    J Clin Epidemiol; 2013 Jul; 66(7):752-8. PubMed ID: 23523551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review finds major deficiencies in sample size methodology and reporting for stepped-wedge cluster randomised trials.
    Martin J; Taljaard M; Girling A; Hemming K
    BMJ Open; 2016 Feb; 6(2):e010166. PubMed ID: 26846897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice?
    Hemming K; Taljaard M
    Int J Epidemiol; 2020 Jun; 49(3):1043-1052. PubMed ID: 32386407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power calculation for detecting interaction effect in cross-sectional stepped-wedge cluster randomized trials: an important tool for disparity research.
    Yang C; Berkalieva A; Mazumdar M; Kwon D
    BMC Med Res Methodol; 2024 Mar; 24(1):57. PubMed ID: 38431550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials.
    Federico CA; Heagerty PJ; Lantos J; O'Rourke P; Rahimzadeh V; Sugarman J; Weinfurt K; Wendler D; Wilfond BS; Magnus D
    Contemp Clin Trials; 2022 Apr; 115():106703. PubMed ID: 35176501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to key recommendations for design and analysis of stepped-wedge cluster randomized trials: A review of trials published 2016-2022.
    Nevins P; Ryan M; Davis-Plourde K; Ouyang Y; Pereira Macedo JA; Meng C; Tong G; Wang X; Ortiz-Reyes L; Caille A; Li F; Taljaard M
    Clin Trials; 2024 Apr; 21(2):199-210. PubMed ID: 37990575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information growth for sequential monitoring of clinical trials with a stepped wedge cluster randomized design and unknown intracluster correlation.
    Brown SP; Shoben AB
    Clin Trials; 2020 Apr; 17(2):176-183. PubMed ID: 32026713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cluster randomised stepped wedge trials with repeated cross-sectional samples.
    Hemming K; Taljaard M; Forbes A
    Trials; 2017 Mar; 18(1):101. PubMed ID: 28259174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator.
    Hemming K; Kasza J; Hooper R; Forbes A; Taljaard M
    Int J Epidemiol; 2020 Jun; 49(3):979-995. PubMed ID: 32087011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group sequential designs for stepped-wedge cluster randomised trials.
    Grayling MJ; Wason JM; Mander AP
    Clin Trials; 2017 Oct; 14(5):507-517. PubMed ID: 28653550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.